Zevra Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 11/12/2025 | 4.04 M | $38.39 M | -1.09% | 7.37% |
| WOODLINE PARTNERS LP | 11/14/2025 | 3.48 M | $33.06 M | -24.69% | 6.35% |
| AIGH CAPITAL MANAGEMENT LLC | 10/31/2025 | 3.22 M | $7.65 M | 100.00% | 5.88% |
| VANGUARD GROUP INC | 11/07/2025 | 3.08 M | $29.32 M | 4.43% | 5.63% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 2.23 M | $21.16 M | -46.62% | 4.06% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 11/14/2025 | 1.97 M | $18.75 M | 33.97% | 3.60% |
| FMR LLC | 11/13/2025 | 1.63 M | $15.54 M | -28.60% | 2.98% |
| STATE STREET CORP | 11/14/2025 | 1.43 M | $13.57 M | 14.95% | 2.61% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 1.30 M | $12.37 M | 4.66% | 2.37% |
| AIGH CAPITAL MANAGEMENT LLC | 10/31/2025 | 1.23 M | $11.72 M | 34.07% | 2.25% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 1.21 M | $11.46 M | 646.48% | 2.20% |
| CAPTION MANAGEMENT, LLC | 11/14/2025 | 1.15 M | $10.93 M | 2,197.60% | 2.10% |
| LEGAL & GENERAL GROUP PLC | 11/13/2025 | 1.05 M | $10.02 M | 12.58% | 1.92% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 1.04 M | $9.85 M | 63.08% | 1.89% |
| CAPTION MANAGEMENT, LLC | 11/14/2025 | 1.00 M | $9.51 M | 900.10% | 1.83% |
| 683 CAPITAL MANAGEMENT, LLC | 11/14/2025 | 975.00 K | $9.27 M | -13.33% | 1.78% |
| MARSHALL WACE, LLP | 11/13/2025 | 912.30 K | $8.68 M | 100.00% | 1.67% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 11/13/2025 | 810.00 K | $7.70 M | 4.43% | 1.48% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 761.78 K | $7.24 M | 103.25% | 1.39% |
| D. E. SHAW & CO., INC. | 11/14/2025 | 725.83 K | $6.90 M | 283.40% | 1.33% |
| ROYCE & ASSOCIATES LP | 11/12/2025 | 691.24 K | $6.57 M | 100.00% | 1.26% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 11/14/2025 | 650.00 K | $6.18 M | 44.44% | 1.19% |
| RETIREMENT PLANNING CO OF NEW ENGLAND, INC. | 11/03/2025 | 600.77 K | $5.71 M | 8.58% | 1.10% |
| MORGAN STANLEY | 11/14/2025 | 555.95 K | $5.29 M | 160.90% | 1.01% |
| CAPTION MANAGEMENT, LLC | 11/14/2025 | 510.09 K | $4.85 M | 100.00% | 0.93% |
| TUDOR INVESTMENT CORP ET AL | 11/14/2025 | 447.90 K | $4.26 M | 100.00% | 0.82% |
| NORTHERN TRUST CORP | 11/14/2025 | 439.48 K | $4.18 M | 3.38% | 0.80% |
| JPMORGAN CHASE & CO | 11/26/2025 | 438.98 K | $4.17 M | 1,458.84% | 0.80% |
| ALGERT GLOBAL LLC | 11/14/2025 | 418.55 K | $3.98 M | 100.00% | 0.76% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 11/13/2025 | 412.55 K | $3.94 M | 30.77% | 0.75% |
| MYSTIC ASSET MANAGEMENT, INC. | 11/03/2025 | 346.65 K | $3.30 M | 0.00% | 0.63% |
| BARCLAYS PLC | 11/12/2025 | 332.44 K | $3.16 M | 218.58% | 0.61% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2025 | 306.49 K | $2.91 M | 2,615.18% | 0.56% |
| TREXQUANT INVESTMENT LP | 11/14/2025 | 302.86 K | $2.88 M | 100.00% | 0.55% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 288.05 K | $2.74 M | 28.68% | 0.53% |
| SQUAREPOINT OPS LLC | 11/14/2025 | 268.08 K | $2.55 M | 100.00% | 0.49% |
| PROPEL BIO MANAGEMENT, LLC | 11/12/2025 | 231.87 K | $2.21 M | 0.00% | 0.42% |
| STRATOS WEALTH PARTNERS, LTD. | 11/06/2025 | 229.00 K | $2.18 M | 4.09% | 0.42% |
| UBS GROUP AG | 11/13/2025 | 218.10 K | $2.07 M | 41.45% | 0.40% |
| JANE STREET GROUP, LLC | 11/14/2025 | 214.20 K | $2.04 M | 43.85% | 0.39% |
| VERITION FUND MANAGEMENT LLC | 11/14/2025 | 193.51 K | $1.84 M | 100.00% | 0.35% |
| CITADEL ADVISORS LLC | 11/14/2025 | 191.80 K | $1.82 M | 67.85% | 0.35% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 187.27 K | $1.78 M | 28.02% | 0.34% |
| JANNEY MONTGOMERY SCOTT LLC | 10/27/2025 | 183.70 K | $1.75 M | -28.43% | 0.34% |
| KOVACK ADVISORS, INC. | 11/10/2025 | 175.28 K | $1.67 M | 19.41% | 0.32% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 173.30 K | $1.65 M | 19.93% | 0.32% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 157.77 K | $1.50 M | -2.59% | 0.29% |
| NUVEEN, LLC | 11/12/2025 | 153.03 K | $1.46 M | 6.92% | 0.28% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2025 | 152.31 K | $1.45 M | 100.00% | 0.28% |
| SIMPLIFY ASSET MANAGEMENT INC. | 10/20/2025 | 147.00 K | $1.40 M | 0.00% | 0.27% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Zevra Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 180 institutional investors and hedge funds held shares of Zevra Therapeutics, Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 4.04 M
Woodline Partners LP: 3.48 M
VANGUARD GROUP INC: 3.08 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 2.23 M
Nantahala Capital Management, LLC: 1.97 M
FMR LLC: 1.63 M
72.78% of Zevra Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 42.80 M shares in the last 24 months. This purchase volume represents approximately $417.27 M in transactions.